AI-generated summary
The authors report an open label pilot study of 30 patients with moderate to severe generalized psoriasis who received a 308 nm excimer laser with clobetasol spray and calcitriol ointment over 12 weeks. At week 12, 25 of 30 patients (83%) achieved PASI-75, and the authors describe a decrease in PGA scores. The authors note that a larger study with control groups is needed.
- Participants
- 30
- Who or what was studied
- Patients with moderate to severe generalized plaque psoriasis
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract describes an open label pilot study without a control group and calls for larger, controlled comparisons.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 308 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Pilot study, Phototherapy, Confidence interval. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.